Roth Capital resumed coverage on Ampio Pharmaceuticals with a new price target

1/24/21 2:54:22 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Roth Capital resumed coverage of Ampio Pharmaceuticals with a rating of Buy and set a new price target of $4.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AMPE

Date	Price Target	Rating	Analyst